Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCF1 | P14598 | 1/20 | 0.41 |
| ▸ | GNAO1 | P09471 | 3/20 | 0.39 |
| ▸ | GNAI3 | P08754 | 2/20 | 0.39 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.39 |
| ▸ | DRD2 | P14416 | 2/20 | 0.38 |
| ▸ | DRD3 | P35462 | 2/20 | 0.38 |
| ▸ | ACHE | P22303 | 3/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | MC4R | P32245 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12440507 | 0.90 | NCF1 (0.45) | NCF1GNAO1GNAI3GNAI1DRD2 | |
| SCHEMBL19313003 | 0.88 | GNAO1 (0.39) | NCF1GNAO1GNAI3GNAI1ACHE | |
| SCHEMBL25565975 | 0.83 | NCF1 (0.42) | NCF1GNAO1GNAI3GNAI1DRD2 | |
| SCHEMBL27365543 | 0.80 | DRD2 (0.41) | DRD2DRD3ACHEBCHE | |
| SCHEMBL25592936 | 0.79 | NCF1 (0.45) | NCF1GNAO1GNAI3GNAI1ACHE | |
| SCHEMBL22305573 | 0.78 | GNAI3 (0.38) | NCF1GNAO1GNAI3GNAI1DRD2 | |
| SCHEMBL22824381 | 0.78 | GNAO1 (0.41) | GNAO1DRD2ACHEHRH3 | |
| SCHEMBL25565977 | 0.78 | NCF1 (0.36) | NCF1DRD2DRD3PGRBCHE | |
| SCHEMBL25565978 | 0.78 | NCF1 (0.36) | NCF1DRD2DRD3PGRBCHE | |
| SCHEMBL25565979 | 0.78 | NCF1 (0.36) | NCF1DRD2DRD3PGRBCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023083194-A1 | WEE1 PROTEIN KINASE DEGRADATION AGENT AND USE THEREOF | 杭州格博生物医药有限公司 | 2023-05-19 | — | — | WO | disclosed |